GlassScriptPhysician profile
Nathan Ryan Smallwood
NPI 1609019934
$13,972.98
in general payments reported to CMS, 2019-2025
40 companies · $893 in 2025
The $893 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,035 · 2020: $317 · 2021: $3,099 · 2022: $1,139 · 2023: $1,099 · 2024: $1,391 · 2025: $893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,383.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,526.76 | 2019-2023 | |
| Abbvie INC. | $1,232.38 | 2020-2025 | Skyrizi, Rinvoq |
| Takeda Pharmaceuticals U.S.A., INC. | $911.63 | 2020-2025 | Entyvio, Eohilia, Gattex |
| Regeneron Healthcare Solutions, INC. | $423.17 | 2022-2025 | Dupixent |
| Genzyme Corporation | $224.93 | 2022-2025 | |
| Ardelyx, INC. | $216.11 | 2022-2025 | Ibsrela |
| Janssen Biotech, INC. | $213.32 | 2022-2025 | Stelara, Simponi, Simponi Aria |
| Qol Medical, LLC | $198.03 | 2023-2025 | Sucraid, Sucraid |
| Thd America, INC. | $187.55 | 2020 | |
| Vivus LLC | $185.46 | 2021-2025 | Qsymia |
| Axonics, INC. | $175.79 | 2021-2023 | Axonics |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $170.48 | 2022-2025 | Xifaxan, Trulance |
| Evoke Pharma, INC. | $121.79 | 2021-2024 | Gimoti |
| Intercept Pharmaceuticals, INC. | $118.40 | 2020-2024 | Ocaliva |
| Gilead Sciences, INC. | $114.62 | 2024 | Livdelzi |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Smallwood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.